Completed × Observational × Thromboembolism × Clear all
NCT03098589 2025-03-30

Revlimid® Capsules Drug Use-results Surveillance (Relapsed or Refractory ATLL)

Celgene

Completed
1,149 enrolled
NCT02921828 2022-07-05

A Safety and Efficacy of Pomalyst® Capsules Under the Actual Use in All Patients Who Are Treated With Pomalyst at a Dose of 1 mg, 2 mg, 3 mg, or 4 mg

Celgene

Completed
1,149 enrolled
NCT03099031 2019-12-16

PREDICARE

LEO Pharma

Completed
420 enrolled
NCT00433602 2013-06-12

Incidence of Blood Clots in Patients Undergoing Chemotherapy for Solid Tumors

European Organisation for Research and Treatment of Cancer - EORTC

Completed
64 enrolled